Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CPH.TOthis companyCipher Pharmaceuticals Inc.	CA$13.57	10.06×	2.22×	5.44×	11.52×	423.7%	65.8%	32.7%	54.2%	22.1%	12.8%	10.8%	0.04×	-0.08×	14.17×	1.12×	0.0%	6	9.06	5	S-
ACB.TOAurora Cannabis Inc.	CA$7.44	-2.13×	0.51×	0.81×	-1.15×	-669.8%	5.2%	-50.8%	-38.0%	-23.8%	-30.2%	-13.9%	0.05×	0.6×	-89.99×	5.94×	0.0%	1	-12.15	2	C+
EDT.TOSpectral Medical Inc.	CA$1.16	-8.47×	-5.93×	169.36×	-10.19×	-125.9%	-211.1%	-478.5%	-1953.0%	68.4%	26.8%	-2.3%	-0.3×	-0.4×	-2.26×	0.08×	0.0%	2	-136.84	2	C
GUD.TOKnight Therapeutics Inc.	CA$11.58	-112.04×	0.79×	1.34×	11.11×	-352.6%	33.5%	-0.5%	-1.2%	-0.7%	-0.2%	11.4%	0.1×	0.03×	-0.21×	2.39×	0.0%	7	3.8	3	B-
HITI.VHigh Tide Inc.	CA$3.74	-7.06×	4.11×	0.61×	-33.62×	183.6%	25.8%	2.6%	-8.5%	-57.9%	5.6%	3.7%	1.71×	-7.42×	1.15×	1.37×	0.4%	2	1.74	2	C+
OGI.TOOrganigram Global Inc.	CA$1.26	-14.84×	1.03×	1.39×	-13.88×	-3094.3%	3.7%	-34.1%	-9.6%	-7.1%	-13.0%	-6.8%	0.03×	3.64×	0×	2.26×	0.0%	5	-0.07	4	A
Peer median	—	-8.47×	0.79×	1.34×	-10.19×	-352.6%	5.2%	-34.1%	-9.6%	-7.1%	-0.2%	-2.3%	0.05×	0.03×	-0.21×	2.26×	0.0%	2	-0.07	2	—